Opus Genetics to Join Russell Indexes, Accesses $12.2 Trillion Benchmarked Assets
IRD•IRD•IRD•IRD•Opus Genetics will join Russell 3000, Russell 2000 and Russell Microcap indexes effective June 29, 2026 following FTSE Russell's reconstitution. Membership exposes the company to benchmarking within $12.2 trillion in assets, potentially boosting passive investment flows and institutional visibility.
Opus Genetics will be added to the Russell 3000®, Russell 2000® and Russell Microcap® indexes when the U.S. market opens on June 29, 2026. The inclusion follows FTSE Russell’s semi-annual reconstitution, which ranks the 4,000 largest U.S. stocks by total market capitalization as of April 30.
Membership in these benchmarks brings Opus into the scope of index-tracking funds and institutional portfolios that collectively benchmark about $12.2 trillion against Russell US indexes. This heightened visibility may drive passive inflows, improve liquidity and broaden the shareholder base for the clinical-stage biopharmaceutical company.
